Is Janus Living, Inc. (JAN) Overvalued?
We dive into why Janus Living, Inc. (JAN) could be considered overvalued on 2026-08-05, based on AAII’s Value Score and Grade.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Janus Living, Inc. is the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT. The firm’s entire portfolio is owned and operated under RIDEA structures. The Firm’s initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. It’s communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025. All of the communities are owned and operated under RIDEA structures. Services provided by the operators under a RIDEA structure are primarily paid for directly by the residents, rather than governmental reimbursement programs, which provides with greater visibility into operating cash flow from our communities. Janus Living, Inc. is based in Denver, Colorado.
Commentary & Analysis
What You Need to Know About Janus Living, Inc.'s Q3 Earnings
Janus Living, Inc.'s fiscal Q3 earnings report was released on Tuesday, August 04. Let's dive in to see if (JAN) missed or beat analyst's expectations.Tudor Pop
Is Janus Living, Inc. (JAN) a Good Dividend Stock?
Learn more about Janus Living, Inc.'s (JAN) dividend history and yield. Also, check out how they are graded based on valuation, growth and strength.Tudor Pop
7 Undervalued Biotechnology & Medical Research Stocks for Thursday, December 07
Discover the top 7 undervalued Biotechnology & Medical Research stocks for Thursday, December 07 based on AAII’s Stock Grades.Jack Gilleland
6 Undervalued Biotechnology & Medical Research Stocks for Tuesday, September 12
Discover the top 6 undervalued Biotechnology & Medical Research stocks for Tuesday, September 12 based on AAII’s Stock Grades.Jenna Brashear
Financial Summary
| Share Statistics | JAN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $7,096.1 | $4,437.3 | 72% |
|
| Shares Out (Mil) | 271.0 | 213.8 | 81% |
|
| Institutional Ownership | 99.9% | 98.7% | 96% |
|
| Float (Mil) | 92.8 | 178.2 | 59% |
|
| Beta | na | 0.76 | na |
|
| Avg Daily Volume (000s) | 2,365 | 1,884 | 84% |
|
| Price Change (52-week) |
na | 91.2% | na |
|
| Growth | JAN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 9.8% | na |
|
| Net Income (5yr) | na | (8.6%) | na |
|
| EPS (5yr) | na | (9.8%) | na |
|
| Dividends (5yr) | na | 0.0% | 59% |
|
| Cash Flow (5yr) | na | (15.0%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 2 | 3 | |
| Current EPS | $0.039 | $0.229 | $0.282 | |
| Month Ago EPS | $0.043 | $0.243 | $0.287 | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | $0.074 | $0.360 | $0.418 | |
| Year/Year Chg | (29.1%) | na | na | |
| Financials | JAN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $723 | $793 | 46% |
|
| Net Income (TTM) (Mil) | $13 | $40 | 47% |
|
| EPS (TTM) | $0.061 | $0.700 | 42% |
|
| Operating Cash Flow (TTM) (Mil) | $179 | $238 | 58% |
|
| Net Cash Flow (TTM) (Mil) | $1,572 | ($1) | 97% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $1,383 | 0% |
|
| Enterprise Value (Q1) (Mil) | $5,989 | $7,667 | 65% |
|
| Valuation | JAN | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.41 | 1.91 | 57% |
|
| P/E | 501.5 | 24.9 | 99% |
|
| Dividend Yield | 1.9% | 5.0% | 75% |
|
| PEG (5yr hist) | na | 1.7 | na |
|
| Ratios | JAN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 30.3% | 61.2% | 35% |
|
| Net Margin | 1.8% | 7.9% | 37% |
|
| ROA | 0.6% | 1.6% | 42% |
|
| ROE | 1.0% | 3.5% | 37% |
|
| Liabilities to Assets | 21.3% | 49.4% | 14% |
|
| F-Score | 3 | 6 | na |
|
Janus Living, Inc. did not pass any screens on 8/20/2026.
